Conestoga Capital Advisors LLC Buys 290,414 Shares of Simulations Plus, Inc. (NASDAQ:SLP)

Conestoga Capital Advisors LLC grew its stake in shares of Simulations Plus, Inc. (NASDAQ:SLP) by 15.0% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The fund owned 2,226,262 shares of the technology company’s stock after buying an additional 290,414 shares during the quarter. Conestoga Capital Advisors LLC owned approximately 11.08% of Simulations Plus worth $62,090,000 as of its most recent SEC filing.

Other institutional investors also recently modified their holdings of the company. State Street Corp raised its position in shares of Simulations Plus by 4.7% during the third quarter. State Street Corp now owns 640,303 shares of the technology company’s stock worth $20,503,000 after acquiring an additional 28,953 shares during the last quarter. Geode Capital Management LLC boosted its stake in Simulations Plus by 4.4% during the third quarter. Geode Capital Management LLC now owns 448,618 shares of the technology company’s stock worth $14,367,000 after acquiring an additional 18,924 shares in the last quarter. Tributary Capital Management LLC grew its holdings in Simulations Plus by 21.7% in the fourth quarter. Tributary Capital Management LLC now owns 396,093 shares of the technology company’s stock worth $11,047,000 after purchasing an additional 70,526 shares during the period. Royce & Associates LP increased its stake in Simulations Plus by 28.8% in the third quarter. Royce & Associates LP now owns 237,416 shares of the technology company’s stock valued at $7,602,000 after purchasing an additional 53,092 shares in the last quarter. Finally, Congress Asset Management Co. raised its holdings in shares of Simulations Plus by 22.5% during the third quarter. Congress Asset Management Co. now owns 206,542 shares of the technology company’s stock valued at $6,613,000 after purchasing an additional 37,914 shares during the period. 78.08% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In other Simulations Plus news, Director Walter S. Woltosz sold 20,000 shares of the stock in a transaction dated Monday, December 2nd. The shares were sold at an average price of $31.76, for a total transaction of $635,200.00. Following the completion of the transaction, the director now owns 3,442,584 shares in the company, valued at $109,336,467.84. This trade represents a 0.58 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 19.40% of the stock is currently owned by insiders.

Analysts Set New Price Targets

Several analysts have recently commented on SLP shares. BTIG Research reduced their target price on Simulations Plus from $60.00 to $50.00 and set a “buy” rating for the company in a research note on Thursday, October 24th. KeyCorp upped their price objective on shares of Simulations Plus from $35.00 to $37.00 and gave the stock an “overweight” rating in a report on Friday, January 24th. Stephens assumed coverage on Simulations Plus in a research note on Friday, November 15th. They set an “overweight” rating and a $39.00 price target for the company. William Blair restated an “outperform” rating on shares of Simulations Plus in a report on Wednesday, January 8th. Finally, StockNews.com cut Simulations Plus from a “hold” rating to a “sell” rating in a research report on Monday, November 4th. One analyst has rated the stock with a sell rating, one has issued a hold rating, five have assigned a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $49.40.

Simulations Plus Price Performance

Shares of NASDAQ:SLP opened at $34.32 on Monday. The company has a market capitalization of $689.49 million, a PE ratio of 85.80 and a beta of 0.82. Simulations Plus, Inc. has a 1 year low of $24.00 and a 1 year high of $51.22. The business has a fifty day moving average price of $30.46 and a two-hundred day moving average price of $32.50.

About Simulations Plus

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.